Outlicensing Opportunities for New Partners. Veriton Pharma is seeking to enhance its corporate offering by way of gaining marketing authorisations for selected products.
Veriton Pharma are now looking to out-licence these products outside of their core UK market to interested partners.
Veriton Pharma is currently seeking potential partners with an interest in the CNS sector to market and distribute an epilepsy medication within the EEA and potentially RoW, outside the UK/Australia/MEA.
If you would be interested in taking one of our products and putting through the licensing program within your country please send us a message using the contact us form to discuss outlicensing opportunities further.
We are committed to developing licensed medicinal products that meet the specific needs of our patients. Veriton Pharma’s portfolio of prescription medicines stems from our team’s deep expertise in the field of epilepsy.
Veriton are pleased to announce their return to The Pharmacy Show this year. We are excited to join pharmacy experts and key opinion leaders, new and existing suppliers and… Read More
SAPHNA Annual Conference 2019: 18th June in Manchester We are delighted to be attending the upcoming SAPHNA Annual Conference; HEALTH FOR ALL CHILDREN – School and Public Health Nurses Turning the Tide…. Read More
Veriton Pharma is pleased to announce the online publication of the charity Young Epilepsy’s online guide for schools. This comprehensive resource aimed at improving the management and support of children with epilepsy… Read More